Vitro Biopharma Inc.
01/22/2024 | Press release | Archived content
Vitro Biopharma Announces Thomas Ohrt New Chief Financial Officer
Vitro Biopharma Announces Thomas Ohrt New Chief Financial Officer
January 22, 2024
Vitro Biopharma Announces New Chief Financial Officer
Golden, Colorado, January 23, 2024 - Vitro Biopharma, Inc., an innovative Biotechnology company announced Thomas W. Ohrt, previously the corporate controller, as Chief Financial Officer, effective January 18, 2024.
- Share:
Please enable JavaScript to view the comments powered by Disqus.
Also in News
Vitro Biopharma Names John Packs to Board of Directors
September 20, 2022 0 Comments
Golden, Colorado, September 23, 2022 - Vitro Biopharma, Inc. is pleased to announce John Packs as the newest member of the company's Board of Directors, appointed on August 2, 2022.
Vitro Biopharma Names Chris Furman Chief Executive Officer
July 18, 2022 0 Comments
Golden, Colorado, July 18, 2022 - Vitro Biopharma Inc. is pleased to announce Chris Furman as Chief Executive Officer and the newest member of the company's Board of Directors.
Mr. Furman is a finance industry leader with more than 25 years' experience in private and public capital markets. Chris has a proven track record of hiring and mentoring successful teams while also building strong and lasting relationships at the senior executive, C-Suite, and Board level. Prior to joining Vitro Biopharma, in his most recent role, Mr. Furman served as Managing Director at Virtus Investment Partnerss.